Table 2.
Descriptive statistics for studies included in the ideation analysis.
| Site | Age HC (years) | Age CC (years) | Age ideation | % female HC | % female CC | % female ideation | Total N HC | Total N CC | Total N Ideation |
|---|---|---|---|---|---|---|---|---|---|
| A. Mood disorders only sample | |||||||||
| Boystown (USA) | 17.0 (14–18) | 17.0 (13–19) | 17.0 (14–18) | 22.2 | 60.0 | 54.4 | 9 | 10 | 11 |
| DEP-ARREST-CLIN – MOODS (France) | 21.0 (20–25) | - | 22.0 (18–25) | 54.5 | - | 70.0 | 11 | 0 | 10 |
| EPISCA (Netherlands) | 14.0 (13–19) | 15.5 (13–16) | 16.0 (13–20) | 86.2 | 83.3 | 88.9 | 29 | 6 | 18 |
| FOR2107-Marburg | 23.0 (18–25) | 24.0 (18–25) | 23.0 (18–25) | 67.2 | 84.4 | 49.1 | 125 | 32 | 57 |
| FOR2107-Münster (Germany) | 23.0 (18–25) | 22.0 (18–25) | 23.0 (19–25) | 71.7 | 77.3 | 50.0 | 106 | 22 | 26 |
| Houston BD (USA) | 14.0 (8–25) | 14.0 (8–25) | 14.0 (10–24) | 54.3 | 31.6 | 66.7 | 81 | 57 | 9 |
| MDD Cohort (China) | 23.0 (22–24) | 22.0 (18–25) | 21.0 (16–25) | 80.0 | 44.4 | 66.7 | 5 | 9 | 12 |
| Muenster Neuroimaging Cohort (Germany) | 22.0 (17–25) | 23.0 (16–25) | 22.0 (17–25) | 47.5 | 57.9 | 50.0 | 80 | 19 | 40 |
| Sydney Brain and Mind Centre (Australia) | 23.0 (18–25) | 19.5 (12–25) | 17.0 (15–22) | 60.0 | 61.4 | 77.8 | 25 | 44 | 9 |
| University of Minnesota (USA) | 16.0 (12–19) | 16.0 (13–20) | 16.0 (12–19) | 54.5 | 74.3 | 84.0 | 22 | 35 | 25 |
| University of Texas- Austin -Bipolar Seed Program (USA) | 21.0 (18–25) | 21.0 (18–25) | 20.5 (19–25) | 69.2 | 75.0 | 83.3 | 26 | 12 | 6 |
| Total | 22.0 (8–25) | 19.0 (8–25) | 20.0 (10–25) | 62.4 | 61.0 | 61.4 | 519 | 246 | 223 |
| B. Transdiagnostic sample | |||||||||
| Boystown (USA) | 17.0 (14–18) | 16.0 (12–19) | 16.0 (12–18) | 22.2 | 30.7 | 63.0 | 9 | 114 | 27 |
| DEP-ARREST-CLIN – MOODS (France) | 21.0 (20–25) | 22.0 (18–25) | 54.5 | 70.0 | 11 | 0 | 10 | ||
| EPISCA (Netherlands) | 14.0 (13–19) | 16.0 (13–20) | 16.0 (12–20) | 86.2 | 83.3 | 87.5 | 29 | 12 | 24 |
| FOR2107-Marburg (Germany) | 23.0 (18–25) | 24.0 (18–25) | 23.0 (18–25) | 67.2 | 84.4 | 49.1 | 125 | 32 | 57 |
| FOR2107-Münster (Germany) | 23.0 (18–25) | 22.0 (18–25) | 23.0 (19–25) | 71.7 | 77.3 | 50.0 | 106 | 22 | 26 |
| Houston BD (USA) | 14.0 (8–25) | 14.0 (8–25) | 14.0 (10–24) | 54.3 | 31.6 | 66.7 | 81 | 57 | 9 |
| MDD Cohort (China) | 23.0 (22–24) | 22.0 (18–25) | 21.0 (16–25) | 80.0 | 44.4 | 66.7 | 5 | 9 | 12 |
| Muenster Neuroimaging Cohort (Germany) | 22.0 (17–25) | 23.0 (16–25) | 22.0 (17–25) | 47.5 | 57.9 | 50.0 | 80 | 19 | 40 |
| SOCAT (Turkey) | 23.0 (17–25) | 23.0 (19–25) | 100.0 | 95.0 | 37 | 0 | 20 | ||
| Sydney Brain and Mind Centre (Australia) | 23.0 (18–25) | 19.0 (12–25) | 20.0 (14–25) | 60.0 | 61.4 | 85.7 | 25 | 83 | 21 |
| University of Minnesota (USA) | 16.0 (12–19) | 16.0 (13–20) | 16.0 (12–19) | 54.5 | 74.3 | 84.0 | 22 | 35 | 25 |
| University of Texas- Austin -Bipolar Seed Program (USA) | 21.0 (18–25) | 21.0 (18–25) | 20.5 (19–25) | 69.2 | 75.0 | 83.3 | 26 | 12 | 6 |
| UWashington/Harvard (USA) | 11.0 (8–16) | 10.5 (8–16) | 14.5 (8–16) | 50.0 | 50.0 | 58.3 | 50 | 24 | 12 |
| Total | 21.0 (8–25) | 17.0 (8–25) | 20.0 (8–25) | 63.7 | 52.5 | 65.7 | 606 | 419 | 289 |
Presented here are age (median, minimum, maximum) and sex for the three groups (HC healthy controls, CC clinical controls, Ideation: group with current suicidal ideation) for the different sites included in the analysis on suicidal ideation in the stage II mood disorder only sample (A) and stage III transdiagnostic sample (B).